Table 2 Association of NIPBL expression with clinical characteristics of 123 patients with lung adenocarcinoma
characteristics | Patients (n = 123), n(%) | NIPBL expression | P | |
|---|---|---|---|---|
Low, n (%) | High, n (%) | |||
Gender | Â | Â | Â | Â |
Male | 81 (65.9) | 52 (61.9) | 29 (74.4) | 0.175 |
Female | 42 (34.1) | 32 (38.1) | 10 (25.6) | Â |
Age (years) | Â | Â | Â | Â |
<50 | 37 (30.1) | 26 (31.0) | 11 (28.2) | 0.757 |
≥50 | 86 (69.9) | 58 (69.0) | 28 (71.8) |  |
Tumor differentiation | Â | Â | Â | Â |
Well differentiated | 34 (27.6) | 29 (34.5) | 5 (12.8) | 0.003 |
Moderately differentiated | 47 (38.2) | 34 (40.5) | 13 (33.4) | Â |
Poorly differentiated | 42 (34.2) | 21 (25.0) | 21 (53.8) | Â |
Lymph node metastasis | Â | Â | Â | Â |
Positive | 81 (65.9) | 50 (59.5) | 31 (79.5) | 0.029 |
Negative | 42 (34.1) | 34 (40.5) | 8 (20.5) | Â |
Disease stage | Â | Â | Â | Â |
I | 36 (29.3) | 26 (31.0) | 10 (25.6) | 0.794 |
II | 53 (43.1) | 36 (42.9) | 17 (43.6) | Â |
III | 34 (27.6) | 22 (26.1) | 12 (30.8) | Â |